相关实验视频
Updated: Jun 25, 2025

07:23
Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
5.9K
氧化应激和炎症参数在心力衰竭中的作用
Karolina Wróbel-Nowicka1, Celina Wojciechowska2, Wojciech Jacheć2
1Medical Laboratory of Teresa Fryda, Katowice, Laboratory Branch in Specialist Hospital in Zabrze, 10, M.C-Skłodowska St., 41-800 Zabrze, Poland.
Medicina (Kaunas, Lithuania)
|May 25, 2024
概括
心力衰竭 (HF) 诊断依赖于像NT-proBNP这样的生物标志物. 本综述探讨了氧化应激和炎症标志物作为HF预后和治疗的有希望的新工具.
科学领域:
- 心脏病学 心脏病学
- 生物标志物 生物标志物
- 病理生理学 病理生理学
背景情况:
- 心力衰竭 (HF) 带来了重大的医疗和社会挑战.
- 目前的黄金标准生物标志物,如NT-proBNP和BNP在预测高温风险方面存在局限性.
- 肝炎病理生理学涉及多种机制,包括氧化应激和炎症.
研究的目的:
- 审查当前关于氧化应激和炎症参数作为心力衰竭生物标志物的知识.
- 突出氧化压力介导炎症在HF发育中的作用.
- 为HF患者确定新的诊断和预后工具.
主要方法:
- 系统的文献审查.
- 在HF中分析氧化应激和炎症参数的分析.
- 评估这些标志物的诊断和预后潜力.
主要成果:
- 氧化应激和炎症对HF进展至关重要.
- 这些生物标志物为高频机制提供了新的见解.
- 氧化应激和炎症标志物显示出HF诊断和预后的前景.
结论:
- 氧化应激和炎症是心力衰竭的关键因素.
- 需要与氧化应激和炎症相关的新生物标志物.
- 这些标记代表了改善高频管理的有希望的途径.
相关概念视频
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
77
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
77
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
421
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
421
Pathophysiology of Cardiac Performance
638
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
638
Heart Failure Drugs: Inotropic Agents
570
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
570
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K

